US 8580927
Engineered antibody constant domain molecules
granted A61PA61P29/00A61P31/16
Quick answer
US patent 8580927 (Engineered antibody constant domain molecules) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P29/00, A61P31/16, A61P31/18, A61P35/00